Assessing possibilities and preventing the risk of using disposables

Introduction The demand scenario for many individual biopharmaceutical drugs such as monoclonal antibodies (MoAbs) is changing. With the implementation of personalised medicine resulting in drugs for specific, high responder subsets of patients, market volume per drug will decrease. In addition inc...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter

We will not sell or give your information to a third party. See our Privacy Policy